Nordic Bioscience A/S

Serum extracellular matrix biomarkers in rheumatoid arthritis, psoriatic arthritis and psoriasis and their association with hand function (2025) Port H, Coppers B, Tragl S, Manger E, Niemiec LM, Bayat S, Simon D, et al. Journal article, Original article Association of Urinary Collagen Type III Degradation Product With Kidney Function and Fibrosis in Chronic Kidney Disease Patients (2025) Martin EM, Genovese F, Mischak H, Siwy J, Rupprecht H, Catanese L, Latosinska A Journal article Association of biochemical markers with bone marrow lesion changes on imaging—data from the Foundation for the National Institutes of Health Osteoarthritis Biomarkers Consortium (2024) Yu SP, Deveza LA, Kraus VB, Karsdal M, Bay-Jensen AC, Collins JE, Guermazi A, et al. Journal article Fibroblast Activation Protein (FAP)-Mediated Cleavage of Type III Collagen Reveals Serum Biomarker Potential in Non-Small Cell Lung Cancer and Spondyloarthritis (2024) Pedersen RS, Thorlacius-Ussing J, Raimondo MG, Langholm LL, Schett G, Ramming A, Karsdal M, Willumsen N Journal article Blood-Based Biomarkers of Inflammation and Tissue Remodeling Can Discriminate Between Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis and Are Associated with Hand Function (2023) Port Linares H, Coppers B, Bayat S, Elie-Tino G, Fagni F, Corte G, Bay-Jensen AC, et al. Conference contribution, Abstract of a poster Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2) (2022) Schett G, Loza MJ, Palanichamy A, Fitzgerald O, Ritchlin C, Bay-Jensen AC, Nielsen SH, et al. Journal article Publisher Correction to: Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2) (Rheumatology and Therapy, (2022), 10.1007/s40744-022-00444-x) (2022) Schett G, Loza MJ, Palanichamy A, Fitzgerald O, Ritchlin C, Bay-Jensen AC, Nielsen SH, et al. Journal article, Erratum Circulating collagen neo-epitopes and their role in the prediction of fibrosis in patients with systemic sclerosis: a multicentre cohort study (2021) Dobrota R, Jordan S, Juhl P, Maurer B, Wildi L, Bay-Jensen AC, Karsdal MA, et al. Journal article Exploring IL-17 in spondyloarthritis for development of novel treatments and biomarkers (2021) Groen SS, Sinkeviciute D, Bay-Jensen AC, Thudium CS, Karsdal MA, Thomsen SF, Schett G, Nielsen SH Journal article, Review article Clinical relevance of collagen protein degradation markers C3M and C4M in the serum of breast cancer patients treated with neoadjuvant therapy in the geparquinto trial (2019) Banys-Paluchowski M, Loibl S, Witzel I, Mundhenke C, Lederer B, Solbach C, Karn T, et al. Journal article